{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:20:38Z","timestamp":1793956838722,"version":"4.8.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.waojou.2023.100765","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T18:12:31Z","timestamp":1681755151000},"page":"100765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Implication of allergy and atopy in IgG4-related disease"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-7195","authenticated-orcid":false,"given":"Katherine","family":"D\u2019Astous-Gauthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1179-8113","authenticated-orcid":false,"given":"Mikael","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-3392","authenticated-orcid":false,"given":"Nicolas","family":"Schleinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.waojou.2023.100765_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.waojou.2023.100765_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/TCRM.S99985","article-title":"IgG4-related disease: current challenges and future prospects","author":"Lang","year":"2016","journal-title":"Therapeut Clin Risk Manag"},{"issue":"9","key":"10.1016\/j.waojou.2023.100765_bib4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","article-title":"Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease","volume":"15","author":"Culver","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","article-title":"Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future","volume":"224","author":"Da\u00ebron","year":"2008","journal-title":"Immunol Rev"},{"issue":"7-8","key":"10.1016\/j.waojou.2023.100765_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2010.02.021","article-title":"Hybrid IgG4\/IgG4 Fc antibodies form upon \u2018Fab-arm\u2019 exchange as demonstrated by SDS-PAGE or size-exclusion chromatography","volume":"47","author":"Rispens","year":"2010","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/imm.12265","article-title":"Estimation of polyclonal IgG4 hybrids in normal human serum","volume":"142","author":"Young","year":"2014","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.waojou.2023.100765_bib8","first-page":"3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J\u00a0Immunol Baltim Md 1950"},{"issue":"1-2","key":"10.1016\/j.waojou.2023.100765_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cellimm.2005.01.001","article-title":"IL-21 effects on human IgE production in response to IL-4 or IL-13","volume":"231","author":"Wood","year":"2004","journal-title":"Cell Immunol"},{"issue":"3-4","key":"10.1016\/j.waojou.2023.100765_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00281-003-0149-8","article-title":"Mechanisms of tolerance to inhalant allergens: the relevance of a modified Th2 response to allergens from domestic animals","volume":"25","author":"Platts-Mills","year":"2004","journal-title":"Springer Semin Immunopathol"},{"issue":"9258","key":"10.1016\/j.waojou.2023.100765_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(00)04168-4","article-title":"Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study","volume":"357","author":"Platts-Mills","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaci.2008.01.072","article-title":"Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity","volume":"121","author":"Francis","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2012.10.048","article-title":"Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens","volume":"131","author":"Vickery","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib15","first-page":"333","article-title":"IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy","volume":"26","author":"Wilcock","year":"2006","journal-title":"Immunol Allergy Clin"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11882-016-0600-2","article-title":"Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions","volume":"16","author":"James","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World allergy organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02338-1","article-title":"Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study","volume":"22","author":"Zhou","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2023.100765_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2017.00235","article-title":"T\u00a0cell polarization toward T(H)2\/T(FH)2 and T(H)17\/T(FH)17 in patients with IgG4-related disease","volume":"8","author":"Grados","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/annrheumdis-2014-206405","article-title":"Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease","volume":"74","author":"Culver","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.waojou.2023.100765_bib25","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/acr.24545","article-title":"Lifetime allergy symptoms in IgG4-related disease: a case-control study","volume":"74","author":"Sanders","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-021-02489-9","article-title":"Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China","volume":"23","author":"Zhao","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib27","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/rheumatology\/keaa651","article-title":"Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients","volume":"60","author":"Lu","year":"2021","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.waojou.2023.100765_bib28","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.waojou.2023.100765_bib29","article-title":"Clinical significance of allergy in IgG4-related disease [abstract]","author":"Zhang","year":"2018","journal-title":"Arthritis Rheumatol [Internet]"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13075-019-1828-8","article-title":"Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.waojou.2023.100765_bib31","doi-asserted-by":"crossref","first-page":"kez280","DOI":"10.1093\/rheumatology\/kez280","article-title":"Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients","author":"Liu","year":"2019","journal-title":"Rheumatology"},{"issue":"50","key":"10.1016\/j.waojou.2023.100765_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002150","article-title":"Intrathoracic involvements of immunoglobulin G4-related sclerosing disease","volume":"94","author":"Fei","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.waojou.2023.100765_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/MEG.0b013e3283297417","article-title":"Allergic manifestations in autoimmune pancreatitis","volume":"21","author":"Kamisawa","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.waojou.2023.100765_bib34","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/ajg.2010.236","article-title":"Eosinophilia and allergic disorders in autoimmune pancreatitis","volume":"105","author":"Sah","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2169\/internalmedicine.53.0963","article-title":"Allergen-specific IgE antibody serologic assays in patients with autoimmune pancreatitis","volume":"53","author":"Kuruma","year":"2014","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14397595.2017.1416891","article-title":"Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: a single-center experience in Japan","volume":"28","author":"Saeki","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.waojou.2023.100765_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0003489415593557","article-title":"Clinical evaluation of sinonasal lesions in patients with immunoglobulin G4-related disease","volume":"124","author":"Takano","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-Related systemic disease: features and treatment response in a French cohort results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.waojou.2023.100765_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.waojou.2023.100765_bib40","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","article-title":"Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort","volume":"59","author":"Liu","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib41","article-title":"Different clinical patterns of IgG4-RD patients with and without eosinophilia","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13075-018-1567-2","article-title":"Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients","volume":"20","author":"Wang","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"10.1016\/j.waojou.2023.100765_bib43","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4103\/0366-6999.184459","article-title":"Types of organ involvement in patients with immunoglobulin G4-related disease","volume":"129","author":"Chen","year":"2016","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.waojou.2023.100765_bib44","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4\u2013related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/joim.12942","article-title":"Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study","volume":"286","author":"Peng","year":"2019","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib46","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800050","article-title":"The expansion in lymphoid organs of IL-4(+) BATF(+) T follicular helper cells is linked to IgG4 class switching in\u00a0vivo","volume":"1","author":"Maehara","year":"2018","journal-title":"Life Sci Alliance"},{"issue":"suppl 10","key":"10.1016\/j.waojou.2023.100765_bib47","article-title":"Salivary gland disease in IgG4-related disease is associated with allergic histories [abstract]","volume":"70","author":"Sanders","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib48","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1038\/s41598-020-62941-9","article-title":"Thymus and activation-regulated chemokine as a biomarker for IgG4-related disease","volume":"10","author":"Umeda","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.waojou.2023.100765_bib49","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00405-018-5013-5","article-title":"IgG4-related disease: association between chronic rhino-sinusitis and systemic symptoms","volume":"275","author":"Gao","year":"2018","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.anai.2020.03.024","article-title":"IgG4-related disease and allergen-specific immunotherapy","volume":"124","author":"Della-Torre","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2023.100765_bib51","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/rheumatology\/keaa221","article-title":"Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes","volume":"59","author":"Lanzillotta","year":"2020","journal-title":"Rheumatology"},{"issue":"41","key":"10.1016\/j.waojou.2023.100765_bib52","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.3748\/wjg.v16.i41.5241","article-title":"Clinical analysis of high serum IgE in autoimmune pancreatitis","volume":"16","author":"Hirano","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"15","key":"10.1016\/j.waojou.2023.100765_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-Related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.12.864","article-title":"Allergy in IgG4-related disease","volume":"141","author":"Matsui","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/14397595.2019.1572488","article-title":"Analysis of allergic reaction in IgG4-related disease","volume":"29","author":"Yamamoto","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"8","key":"10.1016\/j.waojou.2023.100765_bib56","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis. August"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-015-0698-y","article-title":"Clinicopathological characteristics of immunoglobulin G4-related sialadenitis","volume":"17","author":"Li","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.waojou.2023.100765_bib58","series-title":"WAO White Book on Allergy. Update","author":"Pawankar","year":"2013"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2500\/aap.2008.29.3179","article-title":"The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey","volume":"29","author":"Nathan","year":"2008","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/00016489.2010.533699","article-title":"IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease","volume":"131","author":"Moteki","year":"2011","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/his.12775","article-title":"Concomitant occurrence of Mikulicz's disease and immunoglobulin G4-related chronic rhinosinusitis: a clinicopathological study of 12 cases","volume":"68","author":"Piao","year":"2016","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)60305-5","article-title":"Allergy diagnostic testing: an updated practice parameter","volume":"100","author":"Bernstein","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.21037\/jtd.2017.02.73","article-title":"Pulmonary function tests findings and their diagnostic value in patients with IgG4-related disease","volume":"9","author":"Cao","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"issue":"10","key":"10.1016\/j.waojou.2023.100765_bib64","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib65","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatol Oxf"},{"issue":"9","key":"10.1016\/j.waojou.2023.100765_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102889","article-title":"IgG4-related disease and hypereosinophilic syndrome: overlapping phenotypes","volume":"20","author":"Moussiegt","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-019-2090-9","article-title":"Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score","volume":"22","author":"Li","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149330","article-title":"Serum concentrations of IgG4 in the Spanish adult population: relationship with age, gender, and atopy","volume":"11","author":"Carballo","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.anai.2015.12.003","article-title":"Asthma and orbital immunoglobulin G4\u2013related disease","volume":"116","author":"Baqir","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100080","article-title":"IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper","volume":"13","author":"Ansotegui","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib71","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/ar3924","article-title":"Analysis of IgG4 class switch-related molecules in IgG4-related disease","volume":"14","author":"Tsuboi","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1398-9995.2002.5720256.x","article-title":"Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics","volume":"57","author":"Sekiya","year":"2002","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1346-8138.12440","article-title":"Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis","volume":"41","author":"Kataoka","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases","volume":"43","author":"Saeki","year":"2006","journal-title":"J\u00a0Dermatol Sci"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib78","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2017.07.024","article-title":"Expansion of blood IgG(4)(+) B, T(H)2, and regulatory T cells in patients with IgG(4)-related disease","volume":"141","author":"Heeringa","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib79","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000020","article-title":"Activated T-follicular helper 2 cells are associated with disease activity in IgG4-related sclerosing cholangitis and pancreatitis","volume":"10","author":"Cargill","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"10.1016\/j.waojou.2023.100765_bib80","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/art.40556","article-title":"Aberrant expansion and function of follicular helper T cell subsets in IgG4-related disease","volume":"70","author":"Chen","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.waojou.2023.100765_bib81","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39209","article-title":"Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.waojou.2023.100765_bib82","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cyto.2018.05.009","article-title":"Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease","volume":"110","author":"Akiyama","year":"2018","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.waojou.2023.100765_bib83","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1136\/annrheumdis-2012-201477","article-title":"Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"71","author":"Maehara","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.waojou.2023.100765_bib84","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/all.14268","article-title":"Efficacy and safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI guidelines\u2014recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib85","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40257-018-0370-9","article-title":"Dupilumab: a review in moderate-to-severe atopic dermatitis","volume":"19","author":"Frampton","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100765_bib86","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2019-216368","article-title":"Dupilumab as a novel steroid-sparing treatment for IgG4-related disease","volume":"79","author":"Simpson","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.waojou.2023.100765_bib87","article-title":"Comment on article: \u2018Dupilumab as a novel steroid-sparing treatment for IgG 4 -related disease\u2019 by Simpson et\u00a0al.","author":"Ebbo","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.waojou.2023.100765_bib88","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2332\/allergolint.08-OA-0080","article-title":"Polyclonal IgE induces mast cell survival and cytokine production","volume":"58","author":"Kashiwakura","year":"2009","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.waojou.2023.100765_bib90","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1074-7613(01)00159-5","article-title":"Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival","volume":"14","author":"Kalesnikoff","year":"2001","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib91","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1038\/s41598-018-23043-9","article-title":"Mast cells exhibiting strong cytoplasmic staining for IgE and high affinity IgE receptor are increased in IgG4-related disease","volume":"8","author":"Nishida","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.waojou.2023.100765_bib92","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.2013.236","article-title":"T\u00a0helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease","volume":"27","author":"Takeuchi","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.waojou.2023.100765_bib93","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1038\/srep07696","article-title":"Interleukin 13-positive mast cells are increased in immunoglobulin G4-related sialadenitis","volume":"5","author":"Takeuchi","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.waojou.2023.100765_bib94","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00535-012-0626-8","article-title":"Toll-like receptor activation in basophils contributes to the development of IgG4-related disease","volume":"48","author":"Watanabe","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100765_bib95","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.41052","article-title":"Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7\/interleukin-33 signaling","volume":"72","author":"Ishiguro","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.waojou.2023.100765_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/srep42413","article-title":"Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease","volume":"7","author":"Furukawa","year":"2017","journal-title":"Sci Rep"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193945512300025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193945512300025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:46:10Z","timestamp":1761849970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193945512300025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S193945512300025X"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100765","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of allergy and atopy in IgG4-related disease","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100765"}}